The Enterprise Value as of December 2025 (TTM) for Sino Biopharmaceutical Limited (SBHMY) is 111.89B

According to Sino Biopharmaceutical Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 111.89B. This represents a change of 71.14% compared to the average of 65.38B of the last 4 quarters.

Sino Biopharmaceutical Limited (SBHMY) Historical Enterprise Value (quarterly & annually)

How has SBHMY Enterprise Value performed in the past?

The mean historical Enterprise Value of Sino Biopharmaceutical Limited over the last ten years is 75.15B. The current 111.89B Enterprise Value has changed 14.79% with respect to the historical average. Over the past ten years (40 quarters), SBHMY's Enterprise Value was at its highest in in the June 2020 quarter at 165.23B. The Enterprise Value was at its lowest in in the December 2023 quarter at 3.13B.

Sino Biopharmaceutical Limited (SBHMY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sino Biopharmaceutical Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sino Biopharmaceutical Limited (SBHMY) Average Enterprise Value

How has SBHMY Enterprise Value performed in the past?

The current Enterprise Value of Sino Biopharmaceutical Limited (SBHMY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sino Biopharmaceutical Limited (SBHMY) Enterprise Value vs. Peers

How is SBHMY’s Enterprise Value compared to its peers?

Sino Biopharmaceutical Limited’s Enterprise Value is less than WuXi Biologics (Cayman) Inc. (117.12B), less than WuXi Biologics (Cayman) Inc. (117.12B), less than Genmab A/S (118.73B), less than Innovent Biologics, Inc. (136.58B), greater than Straumann Holding AG (14.74B), greater than Straumann Holding AG (14.74B), greater than Orion Oyj (8.72B), less than Astellas Pharma Inc. (4.26T), less than Astellas Pharma Inc. (4.26T), greater than bioMérieux S.A. (12.45B),

Build a custom stock screener for Sino Biopharmaceutical Limited (SBHMY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sino Biopharmaceutical Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sino Biopharmaceutical Limited (SBHMY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sino Biopharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.